201 related articles for article (PubMed ID: 27826370)
21. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
[TBL] [Abstract][Full Text] [Related]
22. Application of drug delivery technologies in lead candidate selection and optimization.
Chaubal MV
Drug Discov Today; 2004 Jul; 9(14):603-9. PubMed ID: 15239979
[TBL] [Abstract][Full Text] [Related]
23. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.
Araújo F; Shrestha N; Granja PL; Hirvonen J; Santos HA; Sarmento B
Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):381-93. PubMed ID: 25495133
[TBL] [Abstract][Full Text] [Related]
24. Cyclodextrin based nanosponges for pharmaceutical use: a review.
Tejashri G; Amrita B; Darshana J
Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895
[TBL] [Abstract][Full Text] [Related]
25. A nanosystem for water-insoluble drugs prepared by a new technology, nanoparticulation using a solid lipid and supercritical fluid.
Park JW; Yun JM; Lee ES; Youn YS; Kim KS; Oh YT; Oh KT
Arch Pharm Res; 2013 Nov; 36(11):1369-76. PubMed ID: 23780798
[TBL] [Abstract][Full Text] [Related]
26. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
[TBL] [Abstract][Full Text] [Related]
27. Multifunctionality of lipid-core micelles for drug delivery and tumour targeting.
Sawant RR; Torchilin VP
Mol Membr Biol; 2010 Oct; 27(7):232-46. PubMed ID: 20929339
[TBL] [Abstract][Full Text] [Related]
28. Preparation of multiparticulate systems for oral delivery of a micronized or nanosized poorly soluble drug.
Cerea M; Pattarino F; Foglio Bonda A; Palugan L; Segale L; Vecchio C
Drug Dev Ind Pharm; 2016 Sep; 42(9):1466-75. PubMed ID: 26786555
[TBL] [Abstract][Full Text] [Related]
29. Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, in vitro and in vivo evaluation.
Dahmani FZ; Yang H; Zhou J; Yao J; Zhang T; Zhang Q
Eur J Pharm Sci; 2012 Aug; 47(1):179-89. PubMed ID: 22683386
[TBL] [Abstract][Full Text] [Related]
30. Sirolimus-loaded polymeric micelles with honokiol for oral delivery.
Li X; Hou X; Ding W; Cong S; Zhang Y; Chen M; Meng Y; Lei J; Liu Y; Li G
J Pharm Pharmacol; 2015 Dec; 67(12):1663-72. PubMed ID: 26454249
[TBL] [Abstract][Full Text] [Related]
31. PEG-lipid micelles as drug carriers: physiochemical attributes, formulation principles and biological implication.
Gill KK; Kaddoumi A; Nazzal S
J Drug Target; 2015 Apr; 23(3):222-31. PubMed ID: 25547369
[TBL] [Abstract][Full Text] [Related]
32. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
33. Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways.
Lapteva M; Santer V; Mondon K; Patmanidis I; Chiriano G; Scapozza L; Gurny R; Möller M; Kalia YN
J Control Release; 2014 Dec; 196():9-18. PubMed ID: 25278258
[TBL] [Abstract][Full Text] [Related]
34. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
[TBL] [Abstract][Full Text] [Related]
35. Polymeric micelles for multi-drug delivery in cancer.
Cho H; Lai TC; Tomoda K; Kwon GS
AAPS PharmSciTech; 2015 Feb; 16(1):10-20. PubMed ID: 25501872
[TBL] [Abstract][Full Text] [Related]
36. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
37. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
Hu L; Tang X; Cui F
J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
[TBL] [Abstract][Full Text] [Related]
38. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
Wang XQ; Zhang Q
Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
[TBL] [Abstract][Full Text] [Related]
39. Pharmaceutical nanotechnology for oral delivery of anticancer drugs.
Mei L; Zhang Z; Zhao L; Huang L; Yang XL; Tang J; Feng SS
Adv Drug Deliv Rev; 2013 Jun; 65(6):880-90. PubMed ID: 23220325
[TBL] [Abstract][Full Text] [Related]
40. Polymeric Micelles as Drug Delivery System: Recent Advances, Approaches, Applications and Patents.
Jain A; Bhardwaj K; Bansal M
Curr Drug Saf; 2024; 19(2):163-171. PubMed ID: 37282644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]